ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
8,393.80
0.85%
S&P ASX All Technology
3,840.60
-1.02%
Brent Oil
74.65
0.00%
US Dollar vs AUD
1.53846
0.06%
Bitcoin
98,481.27
-0.56%
Pepperstone
Advertisement
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Biosenic (BIOS) Share Price

Biosenic

Biosenic (BIOS)

EU
0.0063
0.0002
(3.28%)
Closed 24 November 3:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
0.0063
Bid
0.0058
Offer
0.0064
Volume
856,039
0.0058 Day's Range 0.0063
0.0038 52 Week Range 0.0978
Market Cap
1.028M
Previous Close
0.0061
Open
0.006
Last Trade
100
@
0.0063
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
2,961,545
Shares Outstanding
163,181,000
Dividend Yield
-
PE Ratio
-0.06
Earnings Per Share (EPS)
-0.18
Revenue
545k
Net Profit
-28.78M

About Biosenic

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.biosenic.com
Headquarters
Mont-saint-guibert, Walloon Brabant, Bel
Founded
-
Biosenic is listed in the Biological Pds,ex Diagnstics sector of the Euronext with ticker BIOS. The last closing price for Biosenic was 0.01 €. Over the last year, Biosenic shares have traded in a share price range of 0.0038 € to 0.0978 €.

Biosenic currently has 163,181,000 shares in issue. The market capitalisation of Biosenic is 995,404.10 € . Biosenic has a price to earnings ratio (PE ratio) of -0.06.

Ask ADVFN Intelligence (AI)

BIOS Latest News

More News

BioSenic fait le point sur ses activités du troisième trimestre 2024

BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic fait le point sur ses activités du troisième trimestre 2024 BioSenic lance activement la recherche d'un ou de...

28 October 2024
UK Regulatory

BioSenic provides third quarter 2024 Business Update

BioSenic provides third quarter 2024 Business Update BioSenic provides third quarter 2024 Business Update BioSenic is actively seeking one or more new assets through a merger or acquisition...

28 October 2024
UK Regulatory

BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD.

BioSenic S.A. : Transparency notification received from ABO Infinium Americas OpCo LTD. REGULATED INFORMATION Article 14 of the Law of 2 May 2007 on disclosure of major holdings...

07 October 2024
UK Regulatory

BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD.

BioSenic S.A. : Notification de transparence reçue de la part de ABO Infinium Americas OpCo LTD.  INFORMATION REGLEMENTEE Article 14 de la loi du 2 mai 2007 relative à la publicité des...

07 October 2024
UK Regulatory

BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the composition of its board of directors

BioSenic announces that it has started to look for new assets, the securing of its financing for the coming months by means of an amendment to its convertible bond contract, a change to the...

30 September 2024
UK Regulatory

  BioSenic annonce démarrer la recherche de nouveaux actifs, la sécurisation de son financement pour les prochains mois par le biais d'un avenant à son contrat d'obligations convertibles, une modification de la composition de son conseil

  BioSenic annonce démarrer la recherche de nouveaux actifs, la sécurisation de son financement pour les prochains mois par le biais d'un avenant à son contrat d'obligations...

30 September 2024
UK Regulatory

BioSenic reports half year 2024 results

BioSenic reports half year 2024 results REGULATED INFORMATIONThe interim financial report is prepared in accordance with article 13 of the Royal Decree on the obligations of issuers of financial...

30 September 2024
UK Regulatory

BioSenic publie ses résultats pour le premier semestre 2024

BioSenic publie ses résultats pour le premier semestre 2024 INFORMATION REGLEMENTEELe rapport semestriel est préparé conformément à l’article 13 de l’Arrêté Royal relatif aux obligations des...

30 September 2024
UK Regulatory

Véronique Pomi-Schneiter démissionne de ses fonctions de Directrice Générale Adjointe de BioSenic  

Véronique Pomi-Schneiter démissionne de ses fonctions de Directrice Générale Adjointe de BioSenic   INFORMATION PRIVILIGIEE Mont-Saint-Guibert, Belgique, le 17 septembre 2024, 7h00 CEST –...

17 September 2024
UK Regulatory

Véronique Pomi-Schneiter stands down as BioSenic's Deputy CEO

Véronique Pomi-Schneiter stands down as BioSenic's Deputy CEO PRIVILEGED INFORMATION Mont-Saint-Guibert, Belgium, September 17, 2024 7.00pm CEST – BioSenic (Euronext Brussels and Paris:...

17 September 2024
UK Regulatory
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.000350.0060.0070.005132843920.00557251DE
4-0.0025-28.40909090910.00880.00930.005125465850.00683791DE
12-0.0026-29.21348314610.00890.0160.003829615450.00730029DE
26-0.0126-66.66666666670.01890.0360.003825366150.01155819DE
52-0.0367-85.34883720930.0430.09780.003818703110.01839309DE
156-0.3087-980.3150.350.003811525540.03651263DE
260-0.3087-980.3150.350.003811525540.03651263DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
MLAAHAmatheon Agri Holding NV
0.02 €
(100.00%)
5k
GNROGeNeuro SA
0.0768 €
(25.49%)
200
BIDSGascogne DS
0.005 €
(25.00%)
150.51k
ALSAFSAFE
0.11 €
(23.73%)
39.98k
ALKKOKKO International SA
0.112 €
(21.21%)
4.13M
ALIMOGroupimo
0.189 €
(-40.94%)
392
MLUMGUmalis Group
1.30 €
(-31.22%)
1.71k
MLNMAMiguet Et Associes
0.075 €
(-24.62%)
1.72k
MLSEQSequa Petroleum NV
0.008 €
(-20.00%)
23k
VACBSPierre & Vacances
0.05 €
(-15.25%)
35.99k
BCPBanco Comercial Portugues SA
0.4446 €
(-0.49%)
69.24M
ALNEVNeovacs
0.0002 €
(0.00%)
41.4M
ALCYBCybergun
0.0001 €
(0.00%)
30.32M
INGAING Groep NV
14.652 €
(-1.16%)
14.06M
ACACredit Agricole SA
13.05 €
(-1.66%)
8.06M

Discussion

View Full Feed
HoldHigh HoldHigh 1 minute ago
Like I said before the failure of Amendment 3 in FL will result in more medical patients. Last week FL OMMU indicated there were over 2k new patients added over the last week. I expect these numbers to keep climbing. This is the only legal way to get MJ in FL.
TCNNF
Tiger Money Tiger Money 2 minutes ago
I say it is a scam potentially due to the fda.  That was what I wanted to double check before I bought more 
RDGL
Stock_Barber Stock_Barber 2 minutes ago
They don’t need additional employees.
Sure they do! Who will run the share printing press?


https://investorshub.advfn.com/uimage/uploads/2020/8/7/bzvgrTest.gif
LEEN
govprs govprs 2 minutes ago
Reading the q3 report. Pg 5-6 tells the story of no dilution and getting all the regulatory filings in place to do business.

Pg12 no evidence of any fraudulent activity or history disciplinary actions

Pg 17  demonstrates a profitable qtr 

Pg19 shows they
GDVM
CaptBeer CaptBeer 3 minutes ago
I have written several times to the FDA and to the Senate HELP Committee about the FDA's flawed bioequivalence (AB Rating) System. In the case of skinny labels, it needs to be changed to reflect each indication separately instead of the current system that only references the original drug regardles
AMRN
Tiger Money Tiger Money 3 minutes ago
Awesome color.  Thank you!
RDGL
redspinelpinktopaz redspinelpinktopaz 3 minutes ago
They shouldn't communicate if they have nothing to say. And so far they don't. Let them do their science.
LWLG
Sammy boy Sammy boy 3 minutes ago
Well said, we have something in common, 1 post. per day. This site is in the same company of MSNBC, CNN, old Twitter, Alexa, Canada, Yahoo, FB, Google…..

You say anything about the Pro Trump Truth they penalize you. Falkem !
FNMA
Jetmek_03052 Jetmek_03052 3 minutes ago
No, I don't think it was a fair verdict, as far as the damages amount. And it may have consequences as to the amount of future damages awarded.
NLST
rooster rooster 5 minutes ago
https://x.com/thericanmemes/status/1860062067656655190?s=46&t=qLQnO1TjeygtFbhEqQdlmg
blackcat blackcat 5 minutes ago
I have an excel worksheet for my accounts and the others that I manage. Helps keep me on track for reaching everyone's passive income goals.
JoJr JoJr 5 minutes ago
I had been playing the stock market for 10 years when I hit the biggest winner in 2017.
Did good for the next few years.
RDAR
Patswil Patswil 5 minutes ago
PPS should be $325/share----at a minimum
https://investorshub.advfn.com/uimage/uploads/2022/7/13/ysmlxa22billlion02162022.PNG
FNMA
Longstrongsilver Longstrongsilver 5 minutes ago
That’s not how market cap works lol. Good grief lol. Just buy the dips fool. You can’t have been doing that too often with less than 45k shares here
AZRH
DarkPool DarkPool 6 minutes ago
Gonna blow right by xrp. Half the supply
XRPUSD
Mortimerduke Mortimerduke 6 minutes ago
Flipper44, your investigative analytic skill is more than impressive. Thank you for sharing the knowledge you've accumulated on this complicated subject! Enjoy the rest of your weekend.
NWBO
1vman 1vman 6 minutes ago
*****🟥🟥🟥🚽MJNA 🚽.0005's hitting now !!!! - PEE YEW !! Stinky OTC pinkies here

ENOUGH SAID HUZZAH🤪 !!!
MJNA
pos_stock_hoarder pos_stock_hoarder 6 minutes ago
That was spot on! The hypocrisy is glaring! Any American tradition needs to be trashed but garbage can be worshipped.
RichieBoy RichieBoy 6 minutes ago
The merger was never consummated.
Consequently the LOI's identifications were never disclosed. There's theories these 3 companies are still within reach but no real evidence of that. AFFU wants to acquire the software that was the glue of that merger. Thanks anyways though.
AFFU
FitForStocks FitForStocks 7 minutes ago
Nice write up about HUMBL. I feel the same way and have been buying weekly down here at these prices. My theory is that with the new administration coming into office in January we will see this whole sector change and change rapidly with deregulation and policy shifts. I been saying on other forums
HMBL
jonestint jonestint 7 minutes ago
Haha! Franky Boy just keeps proving me right! Why is this still down 85% from where I sold at 12 cents on Wednesday, February 22, 2023 while saying this?:

MY QUOTE: "Wow. Another example of hot air. I replied to someone saying they thought this would be going higher today. I said to t
CLNV
campe campe 7 minutes ago
On Double Secret Probation watch...??? 
UBQU
Doc logic Doc logic 7 minutes ago
flipper44,

Yes, understood. Goes beyond the work of PD-1 inhibition of T-cell response countered by PD-1 inhibitors like keytruda by moving through another pathway that offers protection from anti PD-1 resistance in tumors known to be resistant to its effect… in multiple tumor types
NWBO
jhdf51 jhdf51 8 minutes ago
Therein lies the problem...nothing says anything about distribution. Now hopes are hanging on any word that has a possible relation to our situation.
Of course people can dream to infinity...there are many that do and that can be healthy to a point but reality is COOP and its future.
COOP
SC8 SC8 8 minutes ago
MK has been saying or implying that IDE is in a great spot for most of the last 10 years. He provided no additional information in yesterday's downdate. Always soon for RDGL, always soon. A decade goes by with no progress, but it's always soon for RDGL.
RDGL

Your Recent History

EU
BIOS
Biosenic
TG
A1Z7BW
HSBC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved